Search

Search Constraints

You searched for: Author/Creator Habermann, Thomas M

Search Results

1. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Issue 11 (November 2018)

2. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study. (18th August 2017)

3. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial. Issue 7 (July 2016)

4. Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis. (31st October 2019)

5. Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial. Issue 6 (June 2020)

6. Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma. Issue 1 (12th November 2017)

8. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. Issue 5 (May 2022)

9. Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study. Issue 4 (April 2022)